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Abstract
Background: The significance of pneumatosis intestinalis (PI) and portal venous gas (PVG) is controversial. This
retrospective study evaluated the risk factors for bowel necrosis in patients with PI and/or PVG.
Methods: Between 2002 and 2015, 52 patients were diagnosed with PI and/or PVG and were included in this study.
The patients were classified according to the presence or absence of bowel necrosis in surgical findings or at autopsy.
Patient characteristics and clinical findings related to bowel necrosis were investigated.
Results: Bowel necrosis was diagnosed in 17 (32.7 %) patients. Amongst these 17, 10 patients received salvage surgical
intervention, and seven of those diagnosed with bowel necrosis survived after the operation. The remaining 35 patients
received conservative treatment with or without exploratory laparotomy. Between patients with and without bowel
necrosis, laboratory data revealed significant differences in the levels of C-reactive protein (P = 0.0038), creatinine (P = 0.
0054), and lactate (P = 0.045); clinical findings showed differences in abdominal pain (P = 0.019) and peritoneal irritation
signs (P = 0.016); computed tomography detected ascites (P = 0.011) and changes of bowel wall enhancement (P = 0.03)
that were significantly higher in patients with bowel necrosis. The rate of PI and/or PVG detected in patients
postoperatively was significantly higher in patients with bowel necrosis (P < 0.0001). Multivariate analysis showed that
bowel necrosis was significantly more likely when PI or PVG was detected in postoperative patients than in patients who
had not had surgery (P = 0.003).
Conclusions: PI and/or PVG, alone, are not automatically indicative of bowel necrosis. However, when these conditions
occur postoperatively, they indicate bowel necrosis requiring reoperation.
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Background
Pneumatosis intestinalis (PI) and the presence of hepatic
portal venous gas (PVG) have long been thought to predict
bowel necrosis and an associated poor prognosis [1–3].
However, widespread use of computed tomography (CT)
has allowed better and more frequent detection of these
conditions [4, 5]. PI and PVG are suggested to have various
sequelae, including bowel necrosis, which are associated
with poor patient outcomes. However, the diagnosis of
bowel necrosis is often difficult in patients with PI and/or
PVG. Accordingly, we investigated patients with PI/PVG
to identify the predictors of bowel necrosis.
Methods
Study groups
Between January 2002 and January 2014, abdominal CT
scan was used to diagnose PI/PVG in 57 patients at the Na-
tional Center for Global Health and Medicine (Tokyo,
Japan). Five patients were excluded from the study due to
1) disturbed consciousness or cardiopulmonary arrest upon
arrival, 2) post-mortem CT, or 3) patient age < 18 years.
The remaining 52 patients were classified as having or not
having bowel necrosis. Bowel necrosis was diagnosed based
on surgical findings and/or postoperative pathologic exami-
nations or autopsies. The clinical characteristics,
* Correspondence: toen0108@gmail.com
1Department of Surgery, National Center for Global Health and Medicine,
1-21-1 Toyama, Shinjuku-ku, Tokyo 162-0054, Japan
27-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Higashizono et al. BMC Surgery  (2016) 16:42 
DOI 10.1186/s12893-016-0158-x
laboratory/imaging findings, and condition severity of the
patients in the two groups were compared to identify the
indicators of bowel necrosis.
CT image interpretation
Study group information was extracted from a database
containing interpretations of imaging studies performed
by experienced radiologists, using the key words: “pneu-
matosis intestinalis (PI)” and “portal venous gas (PVG).”
Gas within 2 cm of the liver border in the contrast-
enhanced images was defined as PVG [1]. If a contrast-
enhanced CT image showed a decrease in bowel wall
enhancement, bowel ischemia was suspected.
PVG evaluation and PI distribution
Patients with PVG were evaluated to determine whether
the amount of gas was a predictor of outcome. PVG
generally expands from the left lobe of the liver to the
right anterior lobe and then to the right posterior lobe
as the amount of gas increases [6]. Therefore, we com-
pared patients with gas confined to the left lobe to those
with gas in the right lobe or in both lobes. PI severity is
reported to be related to its distribution [7], so patients
with PI were classified according to whether they had a
bubble type or linear gas pattern.
Severity evaluation
Disease severity was evaluated using the following three
scoring systems: (1) Acute Physiology and Chronic Health
Evaluation II (APACHE II) score; (2) Sequential Organ
Failure Assessment (SOFA) score; and (3) Systemic In-
flammatory Response Syndrome (SIRS) score. These
scores were calculated using clinical findings and labora-
tory parameters at the time PI/PVG was diagnosed.
Statistical analysis
Statistical analyses were performed using JMP 10 (SAS
Institute, Cary, NC, USA). Univariate analyses were per-
formed using chi-square and Fisher’s exact tests; multivari-
ate analyses were performed using logistic regression




The 52 patients comprised 32 (61.5 %) men and 20
(38.5 %) women, with a mean age of 70.4 years (range,
19–97 years; median, 74 years) (Table 1). Their under-
lying diseases included diabetes, respiratory disease,
oncologic disease, collagen disease, cardiovascular
disease, renal disease, hematological disorder, and in-
flammatory bowel disease; 16 patients (30.7 %) were
taking steroids. Of the included patients, 17 were diag-
nosed with bowel necrosis, and 35 patients were
determined not to have bowel necrosis. In patients
with bowel necrosis, diagnoses included ileus (n = 6),
non-occlusive mesenteric ischemia (NOMI; n = 3), su-
perior mesenteric artery thromboembolism (n = 2),
bowel perforation (n = 2), ischemic enteritis (n = 2),
fatal toxic megacolon (n = 1), and postoperative abscess
(n = 1). In patients without necrosis, diagnoses ranged
from infectious enteritis to simple obstruction; the
cause of symptoms was unknown in 11 patients. Of
the 17 patients with bowel necrosis, 7 (41.2 %) sur-
vived, but required surgical intervention (Table 1). Ten
of the 17 patients died during their hospitalization. Of
the 35 patients without necrosis, 2 died due to pneu-
monia. The incidence of postoperative PI/PVG detec-
tion was significantly higher in patients with bowel
necrosis (P < 0.0001); none of the other patient charac-
teristics was associated with the incidence of detection.
Clinical, laboratory, and imaging findings
Clinical findings included abdominal pain, abdominal
distension, nausea and vomiting, peritoneal irritation
signs, and melena (Table 1). A significant difference
was observed between the two groups with respect to
abdominal pain (P = 0.019) and peritoneal irritation
signs (P = 0.016). Conversely, there were no significant
differences in vital signs. There were also significant
differences in the levels of C-reactive protein (CRP)
(P = 0.0038), creatinine (P = 0.0054), and lactate (P = 0.045)
between the two groups (Table 1). In patients with bowel
necrosis, levels of CRP (10.56 ± 4.01 mg/dL), creatinine
(1.7 ± 0.4 mg/dL), and lactate (4.54 ± 2.03 mmol/L) were
higher than the levels in patients without bowel necrosis.
With respect to patient condition severity, statistically sig-
nificant differences were found between patients with and
without bowel necrosis in the APACHE II, SOFA, and SIRS
scores. The APACHE II (12 ± 2.9), SOFA (2.8 ± 0.9), and
SIRS (1.1 ± 0.5) scores were higher in patients with bowel
necrosis. Among all patients, CT images revealed abdom-
inal ascites in 18 (34.6 %) and free air in 20 (38.5 %)
(Table 1); bowel wall enhancement changes were observed
in 17 patients (32.7 %).
PI was detected in 45 patients (86.5 %), and PVG was
found in 20 (38.5 %), with 13 patients (25 %) exhibiting
both; the presence of PI and/or PVG was not signifi-
cantly related to bowel ischemia, however. Among the
20 patients with PVG, gas was confined to the left lobe
in 12 patients and was seen in the right or in both lobes
in 8. No gas location was significantly associated with
obowel ischemia (P = 0.71). Bowel necrosis was more
frequent in patients with a linear gas pattern, but the dif-
ference was not significant (P = 0.082). However, changes
in bowel wall enhancement were significantly more fre-
quent in patients with bowel necrosis (P = 0.03).
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Table 1 Patient characteristics, clinical findings, laboratory and computed tomography findings
Total Bowel necrosis Non-bowel necrosis
Number (N, (%)) N = 52 N = 17 (32.7) N = 35 (67.3) P value
Age 70.4 ± 5.1 69.5 ± 8.9 70.9 ± 6.2 0.79
Gender 0.74
Male 32 (61.5) 11 21
Female 20 (38.5) 6 14
Underlying disease/condition/treatment
Inflammatory bowel disease 2 (3.8) 0 2 0.31
Respiratory disease 7 (13.5) 2 5 0.8
Diabetes mellitus 10 (19.2) 3 7 0.84
α-Glucosidase inhibitor 5 (9.6) 1 4 0.52
Cardiovascular disease 9 (17.3) 4 5 0.41
Renal disease 4 (7.7) 2 2 0.44
Collagen disease 7 (13.5) 2 5 0.8
Hematological disease 3 (5.8) 0 3 0.21
Steroid therapy 16 (30.8) 4 12 0.43
Chemotherapy 8 (15.4) 3 5 0.75
Postoperative state 9 (17.3) 8 1 0.0001
Tumor-bearing 13 (25.0) 5 8 0.61
Abdominal findings
Abdominal pain 31 (59.6) 14 (82.4) 17 (48.6) 0.019
Peritoneal irritation signs 16 (30.8) 9 (52.9) 7 (20.0) 0.016
Nausea/vomiting 17 (32.7) 7 (41.2) 10 (28.6) 0.36
Abdominal distension 26 (50) 11 (64.7) 15 (42.9) 0.14
Melena 5 (9.6) 1 (5.9) 4 (11.4) 0.52
Vital signs
Temperature 36.9 ± 0.66 37.1 ± 0.5 0.76
Mean blood pressure 79.6 ± 8.9 86.9 ± 7.8 0.24
Pulse rate 94.2 ± 13.6 85.6 ± 11.6 0.34
Respiration rate 19.3 ± 2.6 17.9 ± 1.8 0.36
Laboratory Findings
WBC (×103/μL) 11,992 ± 2811 8654 ± 1988 0.16
Hb (g/dL) 12.3 ± 0.97 11.8 ± 0.68 0.39
Platelets (×103/μL) 18.9 ± 4.1 19.9 ± 2.9 0.67
Total bilirubin (mg/dL) 1.16 ± 0.5 0.90 ± 0.35 0.39
Sodium (mmol/L) 135.2 ± 3.2 137.4 ± 2.3 0.26
Potassium (mmol/L) 4.36 ± 0.34 4.2 ± 0.2 0.49
Arterial pH 7.338 ± 0.065 7.409 ± 0.049 0.81
Base excess (mmol/L) −0.66 ± 0.32 1.22 ± 0.38 0.41
Bicarbonate (mmol/L) 22.39 ± 3.62 24.92 ± 2.61 0.28
Creatinine (mg/dL) 1.7 ± 0.4 0.9 ± 0.3 0.0054
CRP (mg/dL) 10.56 ± 4.01 3.15 ± 2.83 0.0038
Serum lactate (mmol/L) 4.54 ± 2.03 1.90 ± 1.61 0.045
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Treatment and outcomes
Surgery was performed on 11 (21.2 %) patients, and
41 (78.8 %) were treated conservatively (Table 2). Op-
erations included right hemicolectomy with massive
bowel resection (n = 4), alleviation of ileus and partial
small bowel resection (n = 2), intraperitoneal irrigation
and drainage (n = 2), Hartmann’s operation (n = 1),
and exploratory laparotomy (n = 2). One patient who
underwent exploratory laparotomy had a preoperative
diagnosis of sigmoid colon necrosis, but the laparot-
omy did not reveal bowel necrosis. The other patient
undergoing exploratory laparotomy had massive
necrosis extending from the stomach to the large
bowel, and definitive treatment was considered impos-
sible. This patient died. Conservative treatment in-
cluded bowel rest only (n = 13); observation plus
antibiotic therapy (n = 17); decompression via a gas-
tric/ileus tube (n = 6); oxygen therapy, including
hyperbaric oxygen therapy (n = 3); and other treat-
ments (n = 5). Bowel necrosis was suspected in 8
patients receiving conservative treatment, but lapar-
otomies were not performed for various reasons.
Seven of these 8 patients died from deterioration of
their general condition due to bowel necrosis or the
Table 1 Patient characteristics, clinical findings, laboratory and computed tomography findings (Continued)
Evaluation of Severity
SIRS score 1.1 ± 0.5 0.4 ± 0.3 0.036
APACHE II score 12 ± 2.9 7.7 ± 2.1 0.022
SOFA score 2.8 ± 0.9 1.2 ± 0.6 0.0044
Computed tomography findings
Ascites 18 (34.6) 10 (58.8) 8 (22.9) 0.011
Free Air 20 (38.5) 5 (29.4) 15 (42.9) 0.35
Pneumatosis intestinalis (PI) 45 (86.5) 14 (82.3) 31 (88.6) 0.54
linear pattern 23 (51.1) 10 (58.8) 13 (37.1)
bubble pattern 22 (48.9) 4 (23.5) 18 (51.4) 0.082
Portal venous gas (PVG) 20 (38.5) 9 (52.9) 11 (31.4) 0.13
Left lobe 12 (23.1) 5 (29.4) 7 (20)
Right lobe or both lobes 8 (15.4) 4 (23.5) 4 (11.4) 0.71
Both PI and PVG 13 (25) 6 (35.3) 7 (20) 0.23
Deterioration in bowel wall enhancement 17 (32.7) 8 (47.1) 9 (25.7) 0.03
Bubble pattern: gas bubbles in the bowel wall
Linear pattern: continuous gas with a smooth margin
Table 2 Operative method for PI/PVG patients
Treatment Total Bowel necrosis Non-bowel necrosis
N = 52 N = 17 (32.7) N = 35 (67.3) P value
∙ Surgery 11 (21.2) 10 (58.8) 1 (2.9)
Right hemicolectomy ±massive bowel resection 4 4 0
Ileus surgery ± partial small bowel resection 2 2 0
Hartmann’s operation 1 1 0
Intraperitoneal irrigation and drainage 2 2 0
Exploratory laparotomy 2 1 1
∙ Conservative therapy 41 (78.8) 7 (41.2) 33 (97.1)
No oral treatment 13 0 13
No oral treatment + Antibiotic 17 5 12
Decompression via gastric tube 6 2 4
Oxygen therapy 3 0 3
Other 5 0 5
In-hospital deaths 12 (23.1) 10 (58.8) 2 (5.7) <0.0001
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underlying disease. One patient, who probably had
transient bowel ischemia, demonstrated an improved
clinical state and achieved a good outcome.
Univariate/multivariate analyses
In univariate analyses, abdominal pain, peritoneal irrita-
tion, higher CRP, creatinine, and lactate, CT findings of
ascites or reduced bowel wall enhancement, and linear
PI pattern were associated with the presence of bowel
necrosis. Postoperative patients with PI or PVG were
more likely to have bowel necrosis than patients who
had not had surgery (P = 0.003) (Table 3).
Characteristics of patients with postoperatively detected
PI/PVG
Postoperative PI/PVG was detected in 9 (17.3 %) patients
(Table 4). Eight had PI, 4 had PVG, and 3 had both. Eight
of these patients had bowel necrosis; 5 died, and 3 were
successfully treated with further surgical intervention.
One patient developed PI/PVG and NOMI was suspected
after aortic replacement for an abdominal aortic
aneurysm; this individual was treated conservatively.
Discussion
PI is the presence of gas within the submucosa or sub-
serosa of the intestine. A previous study found that the
mean age of PI patients is 56.6 ± 19.4 years and that
57 % of patients were male [8]. PI is a rare disease and is
still poorly understood. Four main theories exist, posit-
ing that PI is caused by: (1) increased intraluminal pres-
sure derived from intestinal obstruction, colonoscopy, or
gastroenteric tumor (mechanical theory); (2) pulmonary
alveolar rupture resulting from pulmonary diseases, such
as chronic obstructive pulmonary disease or asthma
(pulmonary theory); (3) gas produced by gas-forming
bacteria that enter the mucosal barrier (bacterial theory);
or (4) α-glucosidase inhibitors (chemical theory) [9].
However, each theory alone also fails to account for the
cause of PI [2, 3].
PVG is the presence of air in the portal venous system.
The mechanism for the appearance of gas in the portal vein
is also not well understood. There are two major theories:
(1) gas dissects into the intestinal wall from the intestinal
lumen, or lung and intestinal mucosal damage allows intra-
luminal gas to enter the venous system (Mechanical the-
ory); and (2) gas-forming bacteria enter the mucosal barrier
and produce gas within the intestinal wall, which then en-
ters into the portal vein system (bacterial theory) [4, 10].
Previous reports have suggested that PI and PVG usu-
ally originate from bowel necrosis, via similar mecha-
nisms, and are often detected concomitantly in clinical
situations. However, PI and PVG have been studied and
treated as independent symptoms in many publications.
In the current report, we treated patients with PI and/or
PVG as having one condition [5].
PI was previously thought to predict poor outcomes due
to the development of bowel necrosis, but DuBose et al.
evaluated 500 patients with PI and reported that it was not
necessarily associated with bowel necrosis [8]. Similarly,
PVG was also thought to be indicative of a poor prognosis
due to the development of bowel necrosis. This is sup-
ported by the findings of Kinoshita et al., who reported that
the overall mortality rate for patients with PVG was 39 %,
increasing to 75 % in patients with bowel necrosis and only
11.7 % in patients without necrosis [4]. Furthermore, 97 %
of PVG cases were reported to be related to bowel necrosis
[11]. In recent years, the widespread use of CT has enabled
increased detection of PI/PVG, showing that these clinical
signs are not always predictive of a poor outcome. However,
this is because bowel necrosis is not always found in some
patients with PI and/or PVG. The increased sensitivity of
CT scans has increased the detection of PI and PVG, in-
creasing the difficulty of determining whether or not a pa-
tient with PI/PVG has bowel necrosis. Some authors have
reported the development of therapeutic algorithms for
treating PI/PVG [5, 12], but the wide variety of potential
clinical features makes the development of an algorithm
that is applicable to all patients with PI/PVG difficult.
Table 3 Multivariate analysis of predictors of bowel ischemia
Variable 95 % CI P value Odds ratio
Postoperative detection (yes or no) 0.142–7.05 0.003 1.43
Deterioration in bowel wall enhancement (yes or no) 0.021–64.53 0.951 0.894
Abdominal pain (yes or no) 0.0029–5.00 0.234 0.1309
Peritoneal irritation signs (yes or no) 0.00083–17.14 0.213 0.554
Ascites (yes or no) 0.545–269 0.12 0.123
Linear pneumatosis intestinalis pattern (yes or no) 0.00183–2.79 0.207 0.137
Lactate (≥3 or < 3 mmol/L) 0.0892–14.95 0.68 1.96
C-reactive protein (≥3 or <3 mg/dl) 0.0232–16.62 0.89 0.806
Creatinine (≥1.2 or < 1.2 mg/dl) 0.0127–16.72 0.76 1.87
CI Confidence interval
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PI/PVG Preoperative diagnosis Initial surgery Time to postoperative
PI/PVG (days)
Postoperative diagnosis Postoperative treatment Outcome
Yes Male 20 PI Appendicitis Appendectomy 7 Postoperative abscess Open abdominal drainage Alive
Yes Female 84 PI/PVG Sigmoid colon cancer Sigmoidectomy 3 NOMI Exploratory laparotomy Dead
Yes Male 67 PI/PVG Perforated appendicitis Intraperitoneal irrigation and
drainage
1 Perforated appendicitis Intraperitoneal irrigation &
drainage
Dead
Yes Female 48 PI Metastases of uterine
cancer, obstructive ileus
Radical hysterectomy + partial
small bowel resection
24 Obstructive ileus Observation + antibiotic therapy Dead
Yes Female 56 PI Sigmoid colon cancer Sigmoidectomy 3 Anastomotic breakdown Hartmann’s operation +
construction of artificial anus
Alive
Yes Male 74 PI/PVG Esophageal cancer Subtotal esophagectomy 6 Toxic megacolon Observation + antibiotic therapy Dead
Yes Female 55 PI Uterine cancer Total hysterectomy 16 Strangulated ileus Ileus surgery + partial small
bowel resection
Alive
Yes Male 55 PVG Pancreatic head cancer Pancreaticoduodenectomy 15 Postoperative pancreatic
fistula
Observation + antibiotic therapy Dead
No Male 82 PVG AAA Aortic replacement 1 NOMI suspicion Observation + antibiotic therapy Alive












Some clinical findings have also been suggested to
predict bowel necrosis in patients with PI/PVG. Some
reports suggested that bowel necrosis was associated
with the distribution of PVG and bowel gas morph-
ology, though conflicting reports have made this sugges-
tion controversial [7, 13–15]. Bowel necrosis could not
be predicted from the distribution or extent of PVG/PI.
The distribution of PVG was entirely unrelated to bowel
necrosis, whereas linear PI had a nonsignificant associ-
ation with bowel necrosis. Patient characteristics and
past medical histories have been reported to influence
the occurrence of PI/PVG [15, 16], but we found no
such relationship. Many laboratory tests have also been
reported to be useful for the diagnosis of PI/PVG. Some
reports have suggested that blood lactate levels and
acidosis, indicators of tissue necrosis, are predictive of
outcomes [8, 17, 18]. Our univariate analysis showed
that elevated levels of lactate, C-reactive protein, and
creatinine were significantly associated with bowel ne-
crosis. These laboratory parameters are related to tissue
necrosis, inflammation, and dehydration, suggesting
that our findings are reasonable. Furthermore, abdom-
inal physical examination findings are important predic-
tors of bowel necrosis. In particular, signs of peritoneal
irritation have been thought to be useful for diagnosing
peritonitis due to bowel necrosis [19]. Our study sup-
ported this contention, suggesting that both abdominal
pain and signs of peritoneal irritation predict bowel ne-
crosis. However, the assessment of physical findings is
physician-dependent, making an objective or numerical
expression of such findings difficult. Several scoring sys-
tems that evaluate patient condition severity have been
put forth as useful prognostic indicators for patients
with bowel necrosis [20, 21]. In this study, the SIRS,
APACHE II, and SOFA scores were used to assess sever-
ity. All three scores were related to bowel necrosis, indi-
cating that these scores can be useful for evaluating
patients undergoing surgery or conservative treatment.
Recently, procalcitonin and presepsin may indicate use-
ful prognostic information for patients with severe sep-
sis or septic shock. These parameters are expected to be
useful for evaluating the severity of patients’ condition
in the future [22].
PI/PVG is more likely to indicate bowel necrosis in post-
operative patients than in patients who have not had
surgery. There are several reasons that postoperative PI/
PVG may be an indicator of bowel necrosis. First, the pro-
liferation of intestinal bacteria and the production of gas in
the bowel increase the intraluminal pressure, particularly in
patients with postoperative ileus; this may lead to bowel is-
chemia and PI/PVG. Second, inflammatory cytokines in-
crease vascular permeability, and the resulting intravascular
dehydration may cause bowel ischemia [23]. In our study,
the decrease in intravascular fluid, secondary to severe
operative stress and perioperative catecholamine use, may
have caused bowel ischemia in patients who underwent
highly invasive surgeries, such as esophagectomies or pan-
creaticoduodenectomies. Third, the intestine can be dam-
aged during abdominal surgery, and suture failure
sometimes occurs after bowel resection and anastomosis. If
there is massive leakage of bowel contents into the abdom-
inal cavity, re-operation may be required due to bowel ne-
crosis or peritonitis. Moreover, vasoconstrictors or
vasopressors (e.g., catecholamines) are used if the patient’s
blood pressure is unstable. Although vasoconstrictors in-
crease blood pressure, they may also compromise blood
flow to the peripheral intestinal vessels. Excessive vasocon-
striction or repeated alternation of vasoconstriction and
vasodilatation may also induce mesenteric artery spasms,
causing ischemic enteritis or NOMI [24, 25]. Diagnosis of
PI/PVG in postoperative patients is thus a simple indicator
of potential bowel necrosis and may be useful for determin-
ing treatment.
In many cases, PI or PVG occurs in patients who have
not undergone surgery, and it appears to resolve spon-
taneously in many of these patients. This is because PI
or PVG can occur due to transient and reversible intes-
tinal ischemia under certain conditions. For example,
gas-forming bacteria can enter the mucosal barrier,
through mucosal rents or increased mucosal permeabil-
ity, and produce gas within the bowel wall; alternatively,
the intestinal wall may be injured, or increased intralum-
inal pressure may serve as the driving force in PI that
causes the intramural gas, due to conditions such as in-
testinal obstruction, inflammatory bowel disease, bowel
preparation, or colonoscopy.
Our study had several limitations, including being a
retrospective, single-center investigation involving a
small sample size. The PI/PVG and bowel ischemia diag-
noses were dependent upon the subjective judgment of
the attending physicians, leading to potential selection
bias. Furthermore, this study did not evaluate patients
with bowel necrosis who did not have PI and/or PVG,
so the association between PI/PVG and bowel necrosis
cannot be fully assessed. The pathogenesis and clinical
significance of PI/PVG should thus be further investi-
gated in future multicenter prospective studies.
Conclusion
In conclusion, postoperative detection of PI/PVG is indi-
cative of bowel necrosis and is a useful indicator for sur-
geons deciding between further surgical intervention
and conservative therapy.
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